MWI Animal Health and Securos Surgical invest in Serene, LLC to advance novel new therapies toward commercialization

THE WOODLANDS, Texas. September 26, 2017—MWI Animal Health and Securos Surgical, both a part of AmerisourceBergen, have made an investment in the emerging pipeline of Serene, LLC, and will negotiate a distribution partnership with its veterinary subsidiary, Convetra, Inc.

“This investment by MWI and Securos, the leader in veterinary distribution, is an important validation of the potential of our tin-117m in the veterinary marketplace,” said Dennis Steadman, Board Director of Serene, LLC.  “We expect MWI and Securos to provide a valuable partnership in creating a new product category in veterinary medicine.”

The proprietary tin-117m therapies being developed by Serene and Convetra are targeted to treat a variety of medical conditions afflicting companion animals, horses, and humans. Convetra is currently conducting trials in canine osteoarthritis (OA) using tin-117m in a therapeutic approach called radiosynoviorthesis (RSO). In the United States, an estimated 20% of dogs one year of age or older—or about 16 million—are afflicted with some degree of OA.

About AmerisourceBergen.

AmerisourceBergen provides pharmaceutical products, value-driving services, and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices, and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $145 billion in annual revenue. The company is headquartered in Valley Forge, PA and has a presence in more than 50 countries. Learn more at

About Serene, LLC, and Convetra, Inc. Serene is a privately-held company focused on innovating radiolabeled therapeutic and diagnostic products for rheumatology, oncology, and cardiovascular conditions. Its subsidiary, Convetra, is utilizing the power of tin-117m in different formulations to address large areas of unmet need in the veterinary space.

 For more information about AmerisourceBergen, visit

For more information about MWI Animal Health, visit

For more information about Securos Surgical, visit

For more information about Serene, LLC, visit

For more information about Convetra, Inc., visit